GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Liaoning Chengda Biotechnology Co Ltd (SHSE:688739) » Definitions » Total Operating Expense

Liaoning Chengda Biotechnology Co (SHSE:688739) Total Operating Expense : ¥935 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Liaoning Chengda Biotechnology Co Total Operating Expense?

Liaoning Chengda Biotechnology Co's Total Operating Expense for the three months ended in Sep. 2024 was ¥224 Mil. Liaoning Chengda Biotechnology Co's Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2024 was ¥935 Mil.

Liaoning Chengda Biotechnology Co Total Operating Expense Historical Data

The historical data trend for Liaoning Chengda Biotechnology Co's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Liaoning Chengda Biotechnology Co Total Operating Expense Chart

Liaoning Chengda Biotechnology Co Annual Data
Trend Dec13 Dec14 Dec15 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 649.59 733.42 848.44 802.70 871.22

Liaoning Chengda Biotechnology Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 236.23 259.99 204.20 246.13 224.19

Liaoning Chengda Biotechnology Co Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥935 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Liaoning Chengda Biotechnology Co Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Liaoning Chengda Biotechnology Co's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Liaoning Chengda Biotechnology Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Liaoning Chengda Biotechnology Co Ltd (SHSE:688739) » Definitions » Total Operating Expense
Comparable Companies
SZSE:002030 SHSE:688336 SHSE:688443 SHSE:688105 SZSE:002287 BJSE:832982 SZSE:300294 SHSE:688177 SHSE:688639 SHSE:688266 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
No. 1, Xinfang Street, Hunnan New District, Liaoning Province, Shenyang, CHN, 110179
Website
http://www.cdbio.cn
Liaoning Chengda Biotechnology Co Ltd is engaged in the research and development, production and sales of human vaccines.
Executives
Li Ning Director
Cui Jian Wei senior management
Chen Xin senior management
Zhang Shu Min Director
Zhou Li Bao senior management
Yuan De Ming senior management
Gao Jun Director
Yang Xu Director

Liaoning Chengda Biotechnology Co Headlines

No Headlines